Boostrix

Medicinal product

(Invented) name

Boostrix

Active substance (s)

Difterijos anatoksinas/Stabligės anatoksinas/Bordetella pertussis antigenai: Kokliušo anatoksinas/Filamentinis hemagliutininas/Pertaktinas

Strength

>=2 TV/>=20 TV/8 µg/8 µg/2,5 µg

Pharmaceutical form

injekcinė suspensija užpildytame švirkšte

Route (s) of administration

leisti į raumenis

Legal status for supply

Receptinis

Narrow therapeutic index (NTI)

ATC code (s)

J07AJ52, Pertussis, purified antigen, combinations with toxoids

Marketing authorisation holder

UAB Adeofarma, Lietuva

Date of authorisation

2020-09-09

Date of renewal

Documents

Stage

Registruotas

Controlled?

Controlled substance type

Legal basis

Procedure number

Marketing authorisation procedure

Lygiagretus importas

Qualitative and quantitative composition

Dozėje (0,5 ml) yra	0.5 ml
Difterijos anatoksinas	>=2 TV
Stabligės anatoksinas	>=20 TV
Bordetella pertussis antigenai: Kokliušo anatoksinas	8 µg
Filamentinis hemagliutininas	8 µg
Pertaktinas	2,5 µg

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Type of packaging	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To	Mock-up
104986	91088	1091088	užpildytas švirkštas	0,5 ml su 2 adatomis N1	ASPĮ	Receptinis	LT/L/20/1394/001	Netiekiama	-	-	No	-	-	Download

Stadijos

Data	Stadija
2020-09-09	Registruotas